CHRONIC KIDNEY DISEASE AND SYSTEMIC INFLAMMATION

Clinical trials for CHRONIC KIDNEY DISEASE AND SYSTEMIC INFLAMMATION explained in plain language.

Never miss a new study

Get alerted when new CHRONIC KIDNEY DISEASE AND SYSTEMIC INFLAMMATION trials appear

Sign up with your email to follow new studies for CHRONIC KIDNEY DISEASE AND SYSTEMIC INFLAMMATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

New Anti-Inflammation drug tested for kidney patients in china

Disease control Completed

This study tested how the experimental drug ziltivekimab behaves in the body of Chinese adults who have chronic kidney disease along with signs of body-wide inflammation. Twenty-four participants received either the active drug or a placebo dummy injection three times over six mo…

Matched conditions: CHRONIC KIDNEY DISEASE AND SYSTEMIC INFLAMMATION

Phase: PHASE1 • Sponsor: Novo Nordisk A/S • Aim: Disease control

Last updated Mar 31, 2026 12:12 UTC

CHRONIC KIDNEY DISEASE AND SYSTEMIC INFLAMMATION

Get alerted when new CHRONIC KIDNEY DISEASE AND SYSTEMIC INFLAMMATION trials appear

New Anti-Inflammation drug tested for kidney patients in china